The Medicines Company to Participate in the Seventh Annual Needham & Company, LLC...

* Reuters is not responsible for the content in this press release.

Fri Jun 6, 2008 8:05am EDT 

The Medicines Company to Participate in the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference

PARSIPPANY, N.J.--(Business Wire)--
The Medicines Company (NASDAQ: MDCO) is scheduled to present at
The Seventh Annual Needham Biotechnology and Medical Technology
Conference on June 12th, at 3:00pm Eastern Time. A company overview
and outlook will be provided in the presentation.

   The session will be webcast with a link available at The Medicines
Company's website: http://www.themedicinescompany.com.

   MDCO-G

   About The Medicines Company

   The Medicines Company (NASDAQ: MDCO) is focused on advancing the
treatment of critical care patients through the delivery of
innovative, cost-effective medicines to the worldwide hospital
marketplace. The Company markets Angiomax(R) (bivalirudin) in the
United States and other countries for use in patients undergoing
coronary angioplasty, a procedure to clear restricted blood flow in
arteries around the heart. The Company also has two products in
late-stage development, Cleviprex(TM) (clevidipine butyrate)
injectable emulsion and cangrelor. The Company's website is
www.themedicinescompany.com.

The Medicines Company
Robyn Brown, 973-656-1616
Vice President, Investor Relations
investor.relations@themedco.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.